Lawrence Biegelsen
Stock Analyst at Wells Fargo
(0.83)
# 3,194
Out of 4,479 analysts
49
Total ratings
35.71%
Success rate
-21.36%
Average return
Main Sectors:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $7.32 | +173.22% | 6 | Mar 14, 2024 | |
| NVRO Nevro | Maintains: Equal-Weight | $20 → $17 | $8.61 | +97.44% | 10 | Feb 22, 2024 | |
| ABT Abbott Laboratories | Maintains: Overweight | $116 → $121 | $103.20 | +17.25% | 3 | Dec 13, 2023 | |
| PODD Insulet | Maintains: Overweight | $375 → $300 | $196.16 | +52.94% | 2 | Aug 9, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $39.45 | +107.86% | 4 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $211.44 | +17.29% | 1 | Jul 29, 2022 | |
| BDX Becton, Dickinson and Company | Upgrades: Overweight | $275 | $229.27 | +19.95% | 3 | Jun 24, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $436.24 | -22.29% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $3.94 | -61.93% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $6.24 | +332.69% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $105.96 | +4.76% | 2 | Feb 8, 2022 | |
| DXCM DexCom | Upgrades: Overweight | $144 | $112.17 | +28.15% | 1 | Jan 19, 2022 | |
| GKOS Glaukos | Upgrades: Equal-Weight | $56 | $117.42 | -52.31% | 4 | Jan 19, 2022 | |
| MMSI Merit Medical Systems | Maintains: Equal-Weight | n/a | $85.64 | - | 4 | Oct 29, 2021 | |
| EW Edwards Lifesciences | Downgrades: Equal-Weight | n/a | $90.25 | - | 1 | Apr 28, 2020 | |
| NVCR NovoCure | Upgrades: Overweight | n/a | $17.35 | - | 1 | Mar 5, 2020 | |
| GMED Globus Medical | Upgrades: Overweight | n/a | $67.92 | - | 1 | Dec 12, 2019 |
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $7.32
Upside: +173.22%
Nevro
Feb 22, 2024
Maintains: Equal-Weight
Price Target: $20 → $17
Current: $8.61
Upside: +97.44%
Abbott Laboratories
Dec 13, 2023
Maintains: Overweight
Price Target: $116 → $121
Current: $103.20
Upside: +17.25%
Insulet
Aug 9, 2023
Maintains: Overweight
Price Target: $375 → $300
Current: $196.16
Upside: +52.94%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $39.45
Upside: +107.86%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $211.44
Upside: +17.29%
Becton, Dickinson and Company
Jun 24, 2022
Upgrades: Overweight
Price Target: $275
Current: $229.27
Upside: +19.95%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $436.24
Upside: -22.29%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $3.94
Upside: -61.93%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $6.24
Upside: +332.69%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $105.96
Upside: +4.76%
DexCom
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $112.17
Upside: +28.15%
Glaukos
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $117.42
Upside: -52.31%
Merit Medical Systems
Oct 29, 2021
Maintains: Equal-Weight
Price Target: n/a
Current: $85.64
Upside: -
Edwards Lifesciences
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $90.25
Upside: -
NovoCure
Mar 5, 2020
Upgrades: Overweight
Price Target: n/a
Current: $17.35
Upside: -
Globus Medical
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $67.92
Upside: -